Opinion: Pfizer's Dividend Riskier Than It Looks, Even with a 7% Yield
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Compare 401(k) options by evaluating index funds against target date funds to see which aligns with your retirement plan and risk tolerance.
25,660 articlesPfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Many investors worry about a credit squeeze, especially when debt levels rise and lending standards tighten. This gui...
Oklo stock offers a bold long-term thesis in energy tech, but the path is uncertain. This guide helps you answer the ...
NIO delivered a surprising Q4 2025 GAAP profit and outlined a 2026 path to positive non-GAAP earnings, supported by m...
A leading fintech player reveals a real-world crypto use case that could reshape how merchants and consumers transact...
Champion Homes announces a definitive agreement to acquire the majority of Homes Direct assets, expanding its 95-stor...
When a uranium energy stock pops, investors pause to ask what changed and whether the rally can last. This guide brea...
PrimeXBT launches PXTrader 2.0, a major upgrade that merges crypto and traditional markets on a single platform. Trad...
In just one year, Nebius Group has moved from curiosity to a marquee name in AI infrastructure. This piece unpacks wh...
This article dives into why this dividend stock's moat offers unparalleled stability for long-term investors. Discove...
Carvana, known for online used-car sales, is making a curious bet on Stellantis. This article explains the rationale,...
Hormel (HRL) 2026 earnings continue to show resilience in a volatile consumer environment. This deep dive breaks down...